INVESTIGATION NOTICE: Halper Sadeh LLP Investigates TPTX, DRE, CVET, YMTX

NEW YORK, July 6, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Turning Point Therapeutics, Inc. (NASDAQ: TPTX)'s sale to Bristol Myers Squibb for $76.00 per share. If you are a Turning Point shareholder, click here to learn more about your rights and options.  

Duke Realty Corporation (NYSE: DRE)'s sale to Prologis, Inc. for 0.475x of a Prologis share for each Duke Realty share. If you are a Duke Realty shareholder, click here to learn more about your rights and options.  

Covetrus, Inc. (NASDAQ: CVET)'s sale to funds affiliated with Clayton, Dubilier & Rice and TPG Capital for $21.00 per share in cash. If you are a Covetrus shareholder, click here to learn more about your rights and options.  

Yumanity Therapeutics, Inc. (NASDAQ: YMTX)'s sale of its product candidate, YTX-7739, and Yumanity's unpartnered discovery-stage neuroscience product candidates and targets to Janssen Pharmaceutica NV for $26 million in cash, and Yumanity's proposed merger with Kineta, Inc. If you are a Yumanity shareholder, click here to learn more about your rights and options.  

Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com 
https://www.halpersadeh.com

View original content:https://www.prnewswire.com/news-releases/investigation-notice-halper-sadeh-llp-investigates-tptx-dre-cvet-ymtx-301581468.html

SOURCE Halper Sadeh LLP